the strong growth outlook for sandoz, which will create jobs, is expected to partially compensate for necessary reductions in the work force, the firm said in a statement. novartis, which last month forecast record sales for 2005, said it had bought all of germany's hexal. novartis hits acquisition trail swiss drugmaker novartis has announced 5.65bn euros 7.4bn 3.9bn of purchases to make its sandoz unit the world's biggest generic drug producer. this is a very expensive acquisition, birgit kuhlhoff, from sal oppenheim investment bank, told reuters. the deal will see novartis' sandoz business overtake israel's teva pharmaceuticals as the world's biggest maker of generics.